483
Patrick Clarke, M.D.Patrick Clarke, M.D. – FDA 483, May 1, 2021
Record Details
An FDA inspection of Patrick Clarke, M.D. in Los Angeles revealed significant deficiencies in the conduct of a clinical study. The firm failed to adhere to the investigational plan and protocol, including not reporting adverse events and numerous protocol deviations. These issues indicate a lack of proper oversight and execution during the clinical trial.
View Company Profile
ID · 0c1f3d42-0ebd-40a7-b278-bcf4a58560bb
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.